BSE filing, NSE: SHANKESH. Summary written from the filing by ALFA Finder's alert engine.
Shankesh Jewellers Ltd: key numbers
- Share price
- ₹92.10
- Market cap
- ₹1,354 Cr
- Revenue (annual)
- ₹1,631 Cr
- Net profit (annual)
- ₹106.7 Cr
- Promoter holding
- 69.53%
- FII holding
- 3.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shankesh Jewellers Ltd
All →Shankesh Jewellers Investor Presentation: Key Takeaways
Shankesh Jewellers reported strong Q1FY27 results following its August 2026 listing, driven by handcrafted gold jewellery demand and increased corporate client share.
Shankesh Jewellers Q1 FY27 Results: Net Profit ₹43.2 Cr, Up 100.0% YoY
Shankesh Jewellers Ltd reported revenue from operations of ₹423.6 Cr (+55.1% YoY) and net profit of ₹43.2 Cr (+100.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹43.2 Cr · +100.0% YoY
Shankesh Jewellers Other Announcement
Shankesh Jewellers Ltd filed its quarterly shareholding pattern for the period ended August 25, 2026, as required under SEBI regulations.
Shankesh Jewellers Board Meeting Date
Shankesh Jewellers Ltd has scheduled a board meeting for September 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Shankesh Jewellers Credit Rating
CRISIL Ratings revised the outlook on Shankesh Jewellers' Rs. 90 Crore long-term bank facilities to 'Positive' and reaffirmed the 'Crisil BBB' rating.
- Value
- ₹90.00 Cr
Shankesh Jewellers IPO
Shankesh Jewellers Limited has filed documents for its Main Board IPO under the book-building process. The public offering involves equity shares as per SEBI regulations.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.